A modified hollow mesoporous silica nanogel and its preparation method and application
By modifying the hollow mesoporous silica nanogels combined with the ROS-responsive groups thioketal and quercetin, a ROS-responsive nanogel was formed, which solved the problem of drug release control in the treatment of periodontitis and achieved continuous Anti-inflammatory and alveolar bone repair improves therapeutic effects.
Patent Information
- Application Number
- CN202410491383.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-04-23
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2044-04-23
AI Technical Summary
The stability and insufficient drug loading of existing drug carriers in the treatment of periodontitis make it difficult to effectively control drug release, resulting in poor treatment effect.
Using a modified hollow mesoporous silica nanogel, the ROS-responsive group thioketal and quercetin are formed by binding to 3-aminopropyltriethoxysilane, ROS-responsive groups thioketal and quercetin. Pore silica nanogels use ROS-sensitive thioketal bonds to trigger drug release, achieving continuous anti-inflammatory and alveolar bone repair.
It improves the bioavailability of the drug and the alveolar bone repair effect, reduces the toxic side effects of the drug on normal tissues, and provides a new treatment strategy for periodontitis.
Smart Images

Figure CN118340718B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a modified hollow mesoporous silica nanogel and a preparation method and application thereof. Background Art
[0002] At present, nano drug carriers, as an emerging science and technology with market application potential, have been successfully applied in the fields of biomedicine, chemical industry, environment, materials, etc. The research on nano drug carriers mainly focuses on biodegradable inorganic and organic materials. Traditional organic material carriers have low drug loading and unstable physical and chemical properties, which leads to many restrictions on their application in drug delivery systems. Therefore, inorganic materials with high stability and drug loading have received more and more attention. Silica has the advantages of non-toxicity, good biocompatibility and stability, and is widely used in the fields of medicine, catalysis, adsorption, sensors, etc. Hollow mesoporous silica prepared from SiO2 has the advantages of larger specific surface area, easy drug molecule loading and mesoporous core-shell structure, and its application in controlled drug release delivery and disease treatment and diagnosis has been increasingly valued. The drug delivery system with hollow mesoporous silica as the carrier can achieve targeted and sustained drug release, significantly improve the bioavailability of drugs, and reduce the toxic and side effects of drugs on normal tissues and organs.
[0003] Periodontitis is an inflammatory disease of tooth-supporting tissue characterized by progressive destruction of the gums, periodontal ligaments, and alveolar bone. Gingival inflammation and alveolar bone loss are the main clinical symptoms of periodontitis. Periodontitis is one of the most common oral diseases, affecting 60% of the world's population and the main cause of tooth loss in adults. The exact cause of periodontitis is still unclear. Among the many pathogenesis of periodontitis, bone destruction caused by oxidative stress produced by excessive reactive oxygen species has become a hot topic in the current research of bone resorption in periodontitis. In the process of periodontal tissue destruction, in addition to the destruction of gingival tissue by pathogenic bacteria, the immune system also plays an important role. The excessive immune inflammatory response of the host caused by dental plaque bacteria leads to the aggregation of neutrophils, and the reactive oxygen species such as hydrogen peroxide, superoxide anions and hydroxyl free radicals produced by neutrophils are important factors in the destruction of periodontal tissue. Quercetin is widely distributed in the plant kingdom and is a flavonol compound with multiple biological activities, such as anti-inflammatory, antioxidant, anti-apoptotic and anti-osteoporosis, and participates in the body's immune regulation. Quercetin can exert anti-inflammatory effects in vivo and in vitro by inhibiting the expression of inflammatory factors and the activity of inflammatory response proteases. Quercetin can also directly scavenge free radicals and inhibit lipid peroxidation. In addition, quercetin can also promote osteoblast differentiation and inhibit osteoclast formation by regulating the ratio of RANG / OPG.
[0004] Based on the ROS sensitivity of thioketal alcohols, researchers have explored many ROS-responsive drug carriers in recent years by utilizing the high-level ROS environment of diseased tissues. As a widely used ROS-responsive group, thioketal alcohols have high levels of ROS in inflammatory and tumor environments, which can break the thioketal alcohol chemical bonds, thereby triggering the release of drugs. For example, by coupling thioketal alcohols with multi-arm polyethylene glycol (PEG), a hydrogel that degrades in response to high ROS levels in a bone defect environment can be prepared. The TK linker in this hydrogel is cleaved under the action of ROS, resulting in responsive degradation of the hydrogel. In addition, based on the high concentration of ROS in the tumor environment, β-cyclodextrin is connected to the surface of nanoparticles through thioketal alcohols. When the nanoparticles enter the tumor environment, ROS increases rapidly, causing the TK connection to break, releasing triptolide to efficiently kill cancer cells. Summary of the invention
[0005] The purpose of the present invention is to provide a modified hollow mesoporous silica nanogel and a preparation method and application thereof.
[0006] The present invention is achieved through the following technical solutions:
[0007] A modified hollow mesoporous silica nanogel, the structural formula of which is as follows:
[0008]
[0009] Wherein, n is an integer of 35-50, and the average particle size of the modified hollow mesoporous silica nanogel is 200-300 nm.
[0010] The method for preparing the modified hollow mesoporous silica nanogel of the present invention comprises the following steps A to F:
[0011] Step A: The hollow mesoporous silica reacts with 3-aminopropyltriethoxysilane at 75-85° C., and after filtration, the aminated hollow mesoporous silica is obtained, wherein the weight ratio of the hollow mesoporous silica to 3-aminopropyltrimethoxysilane is 1:(0.8-1.2), and the chemical reaction formula is:
[0012]
[0013] Step B: 3-mercaptopropionic acid and anhydrous acetone are mixed, trifluoroacetic acid (TFA) is added, and the mixture is reacted at 15-35° C. After the reaction is completed, the mixture is cooled and crystallized, and filtered to obtain a ROS-responsive group thioketal (TK), wherein the weight ratio of 3-mercaptopropionic acid to anhydrous acetone is 1:(0.8-0.9), and the chemical reaction formula is:
[0014]
[0015] Step C: adding ROS-responsive group thioketal, N-hydroxysuccinimide, 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride, and N,N-diisopropylethylamine to a solvent under the protection of an inert gas, and carrying out a reaction C1 at 15-35° C., adding polyethylene glycol monomethyl ether with an average molecular weight of 1800-2000 after the reaction, and carrying out a reaction C2 at 15-35° C., and evaporating the solvent to obtain mPEG grafted thioketal, wherein the weight ratio of ROS-responsive group thioketal: N-hydroxysuccinimide: 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride: N,N-diisopropylethylamine: polyethylene glycol monomethyl ether is 1: (0.88-0.95): (1.45-1.60): (1.0-1.1): (3.7-3.9), and the chemical reaction formula is:
[0016]
[0017] Step D: adding aminated hollow mesoporous silica and quercetin into a phosphate buffer, reacting at 15-35° C., and obtaining quercetin-loaded aminated hollow mesoporous silica by high-speed centrifugation after the reaction, wherein the weight ratio of aminated hollow mesoporous silica to quercetin is 1:(0.35-0.45);
[0018] Step E: Disperse the quercetin-loaded aminated hollow mesoporous silica (HQU) in a solvent, add 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDCI), N-hydroxysuccinimide (NHS), N,N-diisopropylethylamine (DIPEA), and mPEG grafted thioketal (mPEG-TK), react at 15-35° C. under the protection of an inert gas, and separate to obtain mPEG -TK-terminated quercetin-loaded aminated hollow mesoporous silica, wherein the weight ratio of quercetin-loaded aminated hollow mesoporous silica: N-hydroxysuccinimide: N,N-diisopropylethylamine: 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride: mPEG grafted thioketal is 1: (0.8-1): (1.3-1.6): (1-1.2): (3.5-4.5), and the chemical reaction formula is:
[0019]
[0020] Step F: The mPEG-TK-capped quercetin-loaded aminated hollow mesoporous silica and the thermosensitive hydrogel are mixed in a phosphate buffer to obtain a modified hollow mesoporous silica nanogel, also known as a mPEG-capped ROS-responsive hollow mesoporous silica nanogel containing a thioketal bond.
[0021] Phosphate buffer can be specifically PBS buffer, which is usually based on PB with NaCl added, and has an osmotic pressure and pH value similar to that of human body fluids. In order to meet other requirements, K is sometimes added + , Ca 2+ or Mg 2+ , pH range is 7.2-7.4.
[0022] In detail, in step A, the hollow mesoporous silica reacts with 3-aminopropyltriethoxysilane in an alcohol solvent for 6-24 hours. After the reaction is completed, the filter is filtered and the filter residue is dispersed by ultrasound; the dispersed filter residue is washed with ultrapure water and anhydrous ethanol, and dried to obtain aminated hollow mesoporous silica; the alcohol solvent is selected from at least one of anhydrous ethanol and anhydrous methanol.
[0023] In step B, the reaction time is 4-8 hours, the crystallization temperature is 5 to -5°C, and after filtering, the crystals are washed with at least one of 0-5°C n-hexane, n-heptane, n-hexane, cyclohexane, and petroleum ether, and dried to obtain the ROS-responsive group thioketal.
[0024] In step C, the solvent is selected from at least one of CH2Cl2, chloroform, and 1,2-dichloroethane; the reaction C1 is carried out for 1-6 hours; the reaction C2 is carried out for 40-72 hours; after the solvent is evaporated, the mixture is washed with ether, tetrahydrofuran, or methyl tert-butyl ether and then dried to obtain the mPEG grafted thioacetal.
[0025] In step D, the reaction time is 12-36 hours; the rotation speed range of high-speed separation is 7000-9000 rpm; after separation, the solid is washed with ethanol and / or methanol, and washed with water.
[0026] In step E, the solvent is selected from at least one of dichloromethane, chloroform, and 1,2-dichloroethane; the reaction time is 24-72 hours; after separation, the solid is washed with acetone or ether, washed with water, and then dispersed in ultrapure water and vacuum dried.
[0027] The modified hollow mesoporous silica nanogel of the present invention is used in preparing medicine for treating periodontitis.
[0028] Compared with the prior art, the present invention has the following beneficial effects:
[0029] The present invention provides a mPEG-terminated ROS-responsive hollow mesoporous silica nanogel containing a thioketal bond. This invention has the following advantages:
[0030] 1. The hollow mesoporous structure of hollow mesoporous silica can encapsulate more quercetin.
[0031] 2. mPEG grafted on the surface of hollow mesoporous silica blocks the mesopores of silica and prevents the sudden release of drugs.
[0032] 3. In an inflammatory environment, the ROS-sensitive thioketal alcohol breaks, responsively releasing the encapsulated quercetin and eliminating inflammation. In addition, the cleavage of the thioketal alcohol consumes ROS and relieves oxidative stress under inflammatory conditions. Pharmacological studies have shown that HQUP@Gel can continuously resist inflammation and promote alveolar bone repair and regeneration, providing a new treatment strategy for periodontitis. BRIEF DESCRIPTION OF THE DRAWINGS
[0033] Figure 1 : Particle size images of HMSN, HMSN-NH2, HQU, and HQUP in Example 3;
[0034] Figure 2 : Potential images of HMSN, HMSN-NH2, HQU and HQUP in Example 3;
[0035] Figure 3 : Scanning electron microscope image of HQUP in Example 3;
[0036] Figure 4 : Transmission electron microscope image of HQUP in Example 3;
[0037] Figure 5 : Infrared images of HMSN, HMSN-NH2, mPEG-TK, and HQUP in Example 4;
[0038] Figure 6 : Thermogravimetric images of HMSN, HQU and HQUP in Example 4;
[0039] Figure 7 : Nitrogen isothermal adsorption-desorption curve images of HMSN, HQU and HQUP in Example 5;
[0040] Figure 8 : In vitro release curve of HQUP@Gel in the examples;
[0041] Fig. 9 : H&E staining pictures of periodontal tissue after HQUP@Gel treatment in the example;
[0042] Fig.10 : Micro-CT scan image of periodontium after HQUP@Gel treatment in the embodiment;
[0043] Fig.11 : CCK-8 images of HQUP@Gel in vitro cell compatibility in the examples;
[0044] Fig.12: H&E images of the heart, liver, spleen, lung and kidney of HQUP@Gel in vivo biosafety in the example. DETAILED DESCRIPTION
[0045] The present invention is described in detail below in conjunction with specific embodiments. The following embodiments will help those skilled in the art to further understand the present invention, but are not intended to limit the present invention in any form. It should be noted that, for those of ordinary skill in the art, several variations and improvements may be made without departing from the concept of the present invention. These all belong to the protection scope of the present invention.
[0046] The sources of raw materials used in the present invention are as follows:
[0047] Hollow mesoporous silica (HMSN): Xianfeng Nanomaterials Technology Co., Ltd., Jiangsu, China;
[0048] 3-Aminopropyltriethoxysilane (APTES): Aladdin, Shanghai, China;
[0049] 3-Mercaptopropionic acid: Aladdin, Shanghai, China;
[0050] N-Hydroxysuccinimide (NHS): Aladdin, Shanghai, China;
[0051] 1-Ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDCl): Aladdin, Shanghai, China;
[0052] N,N-Diisopropylethylamine (DIPEA): Aladdin, Shanghai, China;
[0053] Polyethylene glycol monomethyl ether (mPEG) with molecular weight of 1800-2000: Aladdin, Shanghai, China, average molecular weight 1900;
[0054] Quercetin (QU): Aladdin, Shanghai, China;
[0055] Thermosensitive hydrogel: Bio-Tech, Shanghai, China.
[0056] Anhydrous ethanol, anhydrous acetone, ether and dichloromethane were commercially available and of analytical grade.
[0057] Example 1 Preparation of modified hollow mesoporous silica nanogel:
[0058] Step A, preparation of aminated hollow mesoporous silica (HMSN-NH2): weigh 100 mg of hollow mesoporous silica (HMSN) and ultrasonically disperse it in 50 mL of anhydrous ethanol, add 190 mg of APTES under magnetic stirring, reflux at 80°C for 12 h, centrifuge, ultrasonically disperse the precipitate obtained by centrifugation, repeatedly centrifuge and wash with ultrapure water and anhydrous ethanol for multiple times, finally disperse it in ultrapure water and vacuum dry to obtain white solid powder HMSN-NH2.
[0059] Step B, synthesis of ROS-responsive radical thioketal (TK): 5.2 g of 3-mercaptopropionic acid was mixed with 4.6 g of anhydrous acetone, and then 2 mL of trifluoroacetic acid (TFA) was added, and stirred at room temperature (25°C) for 8 h. The above solution was placed in an ice-water mixture to allow TK to crystallize until the crystallization was complete. The product was washed with 4°C n-hexane and dried to obtain the target product TK, which was a white powder.
[0060] Step C, synthesis of mPEG grafted thioketal (mPEG-TK): Under nitrogen protection, 1g TK, 0.92g N-hydroxysuccinimide (NHS), 1.54g 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDCI), 1.04g N,N-diisopropylethylamine (DIPEA) were poured into a beaker containing 60mL of anhydrous dichloromethane and stirred at room temperature for 4h, then 3.8g mPEG was added to the mixed solution and stirred at room temperature for 48h to complete the above reaction. After the sample was rotary evaporated to remove the organic solvent, it was washed with ether and dried to obtain the target product. The end point of the product washing was that the viscous substance turned into a white powder.
[0061] Step D, preparation of quercetin-loaded aminated hollow mesoporous silica (HQU): weigh 50 mg HMSN-NH2, 20 mg quercetin (QU) dispersed in 20 mL phosphate buffer (pH = 7.4), stirred at room temperature for 24 h, then heated to 37 ° C, continued to incubate for 24 h, centrifuged at 8000 rpm, washed 3 times with ethanol and 3 times with water to ensure that there are no drug molecules adsorbed on the surface of the nanoparticles, and collected the supernatant for subsequent encapsulation efficiency determination.
[0062] Step E, preparation of mPEG-TK-terminated quercetin-loaded aminated hollow mesoporous silica (HQUP): 100 mg of quercetin-loaded aminated hollow mesoporous silica (HQU) was suspended in 10 mL of dichloromethane and ultrasonically treated for 1 h. 90 mg of 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride, 60 mg of N-hydroxysuccinimide and 400 mg of mPEG grafted thioketal (mPEG-TK) were added. Stir at room temperature for 48 h under nitrogen protection. Wash three times with acetone and three times with water to remove unreacted mPEG-TK and other reagents, purify the obtained product mPEG-TK-terminated quercetin-loaded aminated hollow mesoporous silica (HQUP), and vacuum dry at room temperature for 24 h.
[0063] Step F, preparation of modified hollow mesoporous silica nanogel: weigh 0.2 g mPEG-TK-capped quercetin-loaded aminated hollow mesoporous silica, 2.2 g thermosensitive hydrogel F127, add 10 mL phosphate buffer to prepare 10 mL of 22% modified hollow mesoporous silica nanogel.
[0064] Note: F127 is a thermosensitive hydrogel composed of a triblock copolymer of polyoxyethylene-polyoxypropylene-polyoxyethylene (PEO-PPO-PEO).
[0065] Example 2 Determination of encapsulation efficiency and drug loading rate of hollow mesoporous silica nanoparticles loaded with quercetin:
[0066] The mass of QU initially added in the experiment was recorded as W1; the supernatant obtained in Example 1, step D, was measured by ultraviolet spectrophotometer, and the mass of free QU was calculated and recorded as W2. The quercetin-loaded hollow mesoporous silica was dried by freeze drying, and the weight obtained was recorded as W3. The encapsulation efficiency and drug loading were calculated according to the following formula:
[0067] EE(%)=(W1-W2) / W1
[0068] LE(%)=(W1-W2) / W3
[0069] According to the experimental results, EE=92.57±0.84% and LE=25.42±0.35% were calculated.
[0070] Example 3 Characterization of quercetin-loaded hollow mesoporous silica particle size, potential, SEM, and TEM:
[0071] The hydrated particle size was measured by Malvern particle size analyzer, and the particle size potential changes of HMSN, HMSN-NH2, HQU, and HQUP were analyzed. Figure 1The results show that the particle size of HMSN is 93.3 nm, and the particle size of HMSN-NH2 after amino modification increases to 123.56 nm. Figure 2 As shown, the potential of HMSN is -18.32±0.3mV. After amino modification, the potential changes from negative to positive. This is because the amino groups on its surface are easily protonated in water and thus carry a positive charge. This indirectly proves that the amino modification of HMSN is successful, and the potential value is 18.27±0.88mV. When the carboxyl groups of the mPEG-TK molecules react with the amino groups on the surface of HMSN for amide cross-linking, a part of the amino groups on the surface of HMSN are occupied by folic acid molecules, thereby shielding part of the positive charge of the amino HMSN. In addition, the carboxyl groups of mPEG-TK will be deprotonated and carry a certain negative charge, resulting in a decrease in the charge of the finally prepared HQUP. The morphology of HQUP was further observed by transmission electron microscopy (TEM) and scanning electron microscopy (SEM). The SEM results are shown in Figure 3 As shown in Figure 1, the HQUP morphology is regular and spherical. Figure 4 As shown, HQUP has uniform particle size, obvious internal hollow cavity structure, and intact external mesoporous shell.
[0072] Example 4 Infrared and thermogravimetric characterization of HQUP:
[0073] The infrared characteristic peaks and functional groups of HMSN, HMSN-NH2, HQU and HQUP were determined by AVATAR 370 infrared spectrometer (Thermo USA). The samples were mixed with dry potassium bromide powder and the infrared spectra were measured at 4000 to 400 cm -1 The infrared spectrum results are as follows Figure 5 As shown, compared with HMSN, HMSNs-NH2 has a -1 The single peak at 1490cm-1 was transformed into a double peak, indicating the appearance of the symmetrical stretching vibration absorption peak of -NH2, indicating that -NH2 was successfully modified on the surface of HMSNs. In the infrared spectrum of HQUP, after mPEG capping, the CN stretching vibration appeared at 1490cm-1. -1 , confirming the formation of the amide bond, while 2872 cm -1 The absorption peak at is attributed to the characteristic absorption of the methylene group on the PEG chain segment. The above results all indicate that mPEG is successfully capped on the surface of HMSNs. The specific ratio of thermally decomposable and non-thermally decomposable components in the system was characterized using a Q500 thermal analyzer (TA, USA). The TGA curve is shown in Figure 2. Figure 6Compared with HMSNs, HMSNs-NH2 lost 2% more weight, which may be due to the grafting of -NH2 on the surface. When quercetin was encapsulated, the weight loss of HQU increased further. Compared with HQU, HQUP had the highest weight loss ratio, which may be because HMSN is not easy to decompose, and the weight loss ratio gradually increased due to the increase in the proportion of easily decomposable substances such as modified amino groups, encapsulated drugs and capped mPEG.
[0074] Example 5 HQUP specific surface area and mesopore characterization:
[0075] The nitrogen adsorption-desorption curve was measured by a fully automatic specific surface and porosity analyzer. The HQUP specific surface area was calculated using the BET method, the BJH adsorption-desorption was used for mesopore analysis, and the pore size distribution was analyzed using the BJH adsorption isotherm. The nitrogen isotherm adsorption-desorption curve is shown in Figure 2. Figure 7 As shown, HMSN belongs to the type IV isotherm curve and has an obvious hysteresis loop. This is because when nitrogen is adsorbed into the mesopores, the resistance to adsorption is small and it is easy to proceed. When the pressure drops, the resistance to nitrogen desorption is large, resulting in incomplete nitrogen desorption, that is, the remaining adsorption amount is greater than the nitrogen adsorption amount at the same pressure, so the adsorption and desorption isotherms do not overlap, forming a hysteresis loop. The isotherms of HMSNs are changed due to the filling of quercetin molecules, and its adsorption amount is much smaller than that of HMSNs. Studies have shown that the specific surface area of HMSNs is 1086.42m 2 / g, the pore size is 5.42nm, while the specific surface area of HQU decreases sharply due to the loading of quercetin, and the specific surface area is 475.86m 2 / g, the pore size slightly decreased to 4.85nm, which also proved that quercetin successfully occupied the mesoporous structure of HMSNs. When HQU was capped with mPEG, the specific surface area and pore volume decreased rapidly, indicating that mPEG covered most of the pores of HMSN. The above results also confirmed the successful capping of mPEG on the surface of HQU.
[0076] Example 6 In vitro drug release of HQUP@Gel:
[0077] HQU and HQUP were dispersed in 2 mL of PBS buffer containing 1% Tween-80 with or without H2O2, sealed in a dialysis bag, and then immediately immersed in 50 mL of buffer solution. Place in a constant temperature shaker at 37±0.5°C. 2 mL of release medium was drawn at 1, 2, 4, 8, 12, 24, 36, 48, 72, 96, and 120 h, and an equal volume of fresh medium was added. The peak area of QU was analyzed at 360 nm by HPLC, and the concentration of QU was calculated according to the standard curve. The following formula was used to obtain the cumulative drug release percentage and draw the drug release curve. The cumulative release degree Q was calculated according to the following formula:
[0078]
[0079] Where Cn represents the mass concentration of each component to be tested at the nth sampling, V represents the volume of each sampling, W represents the QU content in the tested gel, and each sample is tested in parallel 3 times. The cumulative release amount Q% at each time point is calculated, and the in vitro release curve of the drug is drawn with each time point as the horizontal axis and the cumulative release amount Q% as the vertical axis.
[0080] The results are as follows Figure 8 As shown in the figure, when there is no H2O2, QU is released slowly, about 1 / 4 is released within 12 hours, and the cumulative release of QU is only 50% after the experiment. When H2O2 is added to the release medium, the release rate of QU increases rapidly. The release amount exceeds 50% within 12 hours, which is 1 times higher than before. At the end of the experiment, the cumulative release of QU reaches 85%. The above results show that HQUP has good ROS response ability.
[0081] Example 7 Pharmacodynamic evaluation of HQUP@Gel in treating periodontitis in rats:
[0082] The rat model of periodontitis was established by silk ligation combined with LPS and Porphyromonas gingivalis injection. The specific operation was as follows: After one week of adaptive feeding of healthy SPF male rats, 3% sodium pentobarbital (30 mg / kg) was used for intraperitoneal anesthesia in all groups except the normal group. The rats were placed supine on the experimental table, the head and limbs of the rats were fixed, the upper and lower jaws were pulled to fully expose the left maxillary first molar, and a 0.2 mm ligature was passed through the gap between the first and second molars of the rats, ligated at the neck of the first molar, and tied on the palate side. The excess length of the ligature was cut off, and the ligature was buried under the gums. LPS and Porphyromonas gingivalis were injected every 3 days. The periodontal condition of the rats was observed after 4 weeks. The first molar gums were red, swollen and congested, bleeding was detected, the periodontal pocket was detected, the alveolar bone was absorbed, and the teeth were slightly loose. The rats with successful modeling were randomly divided into: normal group, model group, HQUP@Gel, and positive drug group. Every 3 days, 25 μL of the corresponding preparation was injected subperiosteally at the top of the central alveolar ridge on the buccal and palatal sides of the maxillary first molar, and the normal group and the model group were injected with the same volume of saline. Four weeks later, the rats were killed by intraperitoneal injection of an overdose of sodium pentobarbital, the left maxilla was separated, the blood stains were cleaned with saline, and the tissues near the first molar were collected, rinsed, and stored at -80°C. The excess soft tissue was removed with fine scissors, and the specimens were fixed in 4% paraformaldehyde for 48 hours. The tooth specimens were removed and placed in 10% EDT solution for decalcification, gradient ethanol dehydration, paraffin embedding, and sectioning.
[0083] In order to study whether HQUP@Gel can inhibit periodontal tissue inflammation, the distribution of inflammatory cells was observed by H&E staining. Fig. 9 As shown in the figure, the periodontal tissue structure of the normal group was clear, there was no alveolar bone absorption, and almost no inflammatory cell infiltration was observed. However, in the periodontitis model group, the interdental papilla disappeared in the maxillary first and second molars, and the junctional epithelium migrated to the root to form a deep periodontal pocket. The periodontal fiber structure was disordered, and resorptive pits were visible in the cementum, and a large number of inflammatory cell infiltrations could be found in the surrounding areas. After HQUP treatment, the level of inflammation in the rat gingival tissue decreased significantly, and the infiltration of inflammatory cells was effectively alleviated.
[0084] In order to study the alveolar bone regeneration, Micro-CT was used to scan the maxilla and observe the alveolar bone of the maxillary first molar of rats. Fig.10 As shown in the figure, there was no obvious alveolar bone defect in the control group. The alveolar bone defect in the periodontitis model group was significant, with exposed tooth roots and obvious root bifurcation, indicating that the rat periodontitis model was successfully established. The alveolar bone in the HQUP@Gel group was significantly restored, close to that of the blank control group.
[0085] Example 8 HQUP@Gel biocompatibility experiment:
[0086] The CCK8 assay was used to test the proliferation activity of HQUP@Gel on human periodontal ligament stem cells and macrophages to verify the in vitro safety of the preparation. Fig.11 As shown in the figure, HQUP@Gel exhibits good cell compatibility. In vivo biocompatibility evaluation of HQUP@Gel: After the experiment, rats were killed by intraperitoneal injection of an overdose of sodium pentobarbital, and the heart, liver, spleen, lung, and kidney were removed. After fixation with 4% paraformaldehyde for 24 hours, the cells were dehydrated in gradient ethanol, embedded in paraffin, and sliced. The histological morphology of each organ was observed after H&E staining. The H&E results are shown in the figure. Fig.12 As shown in the figure, compared with the blank control group, the histological morphology of the heart, liver, spleen and kidney in the HQUP@Gel group was basically the same, and no obvious abnormalities were shown. The above results show that the HQUP@Gel prepared in this study has no obvious toxicity and can be used for in vivo and in vitro research.
Claims
1. A method for preparing a modified hollow mesoporous silica nanogel, characterized in that: The following steps are involved: Step A: The hollow mesoporous silica reacts with 3-aminopropyltriethoxysilane at 75-85°C, and after filtration, the aminated hollow mesoporous silica is obtained, wherein the weight ratio of the hollow mesoporous silica to 3-aminopropyltrimethoxysilane is 1:(0.8-1.2), and the chemical reaction formula is: ; Step B: After 3-mercaptopropionic acid and anhydrous acetone are mixed, trifluoroacetic acid is added, and the mixture is reacted at 15-35°C. After the reaction is completed, the mixture is cooled and crystallized, and filtered to obtain the ROS-responsive group thioketal, wherein the weight ratio of 3-mercaptopropionic acid to anhydrous acetone is 1:(0.8-0.9), and the chemical reaction formula is: ; Step C: Add ROS-responsive group thioketal, N-hydroxysuccinimide, 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride, and N,N-diisopropylethylamine to a solvent under the protection of an inert gas, and carry out reaction C1 at 15-35° C. After the reaction, add polyethylene glycol monomethyl ether with an average molecular weight of 1800-2000, and carry out reaction C2 at 15-35° C., and evaporate the solvent to obtain mPEG grafted thioketal, wherein the weight ratio of ROS-responsive group thioketal: N-hydroxysuccinimide: 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride: N,N-diisopropylethylamine: polyethylene glycol monomethyl ether is 1: (0.88-0.95): (1.45-1.60): (1.0-1.1): (3.7-3.9), and the chemical reaction formula is: ; Step D: adding aminated hollow mesoporous silica and quercetin into phosphate buffer, reacting at 15-35° C., and obtaining quercetin-loaded aminated hollow mesoporous silica by high-speed centrifugation after the reaction, wherein the weight ratio of aminated hollow mesoporous silica to quercetin is 1:(0.35-0.45); Step E: Dispersing the quercetin-loaded aminated hollow mesoporous silica in a solvent, adding 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride, N-hydroxysuccinimide, N,N-diisopropylethylamine, and mPEG grafted thioketal, reacting at 15-35° C. under the protection of an inert gas, and obtaining mPEG-TK-terminated quercetin-loaded aminated hollow mesoporous silica after separation, wherein the weight ratio of quercetin-loaded aminated hollow mesoporous silica: N-hydroxysuccinimide: N,N-diisopropylethylamine: 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride: mPEG grafted thioketal is 1: (0.8-1): (1.3-1.6): (1-1.2): (3.5-4.5), and the chemical reaction formula is: ; Step F: The aminated hollow mesoporous silica loaded with quercetin capped with mPEG-TK is mixed with the thermosensitive hydrogel F127 in a phosphate buffer to obtain a modified hollow mesoporous silica nanogel.
2. The method for preparing the modified hollow mesoporous silica nanogel according to claim 1, characterized in that: In step A, the hollow mesoporous silica reacts with 3-aminopropyltriethoxysilane in an alcohol solvent for 6-24 hours. After the reaction is completed, the filter is filtered and the filter residue is dispersed by ultrasound; the dispersed filter residue is washed with ultrapure water and anhydrous ethanol, and dried to obtain aminated hollow mesoporous silica; the alcohol solvent is selected from at least one of anhydrous ethanol and anhydrous methanol.
3. The method for preparing the modified hollow mesoporous silica nanogel according to claim 1, characterized in that: In step B, the reaction time is 4-8 hours, the crystallization temperature is 5 to -5°C, and after filtering, the crystals are washed with at least one of 0-5°C n-hexane, n-heptane, cyclohexane, and petroleum ether, and dried to obtain the ROS-responsive group thioketal.
4. The method for preparing the modified hollow mesoporous silica nanogel according to claim 1, characterized in that: In step C, the solvent is selected from at least one of CH2Cl2, chloroform, and 1,2-dichloroethane; the reaction C1 is carried out for 1-6 hours; the reaction C2 is carried out for 40-72 hours; after the solvent is evaporated, the mixture is washed with ether, tetrahydrofuran, or methyl tert-butyl ether and then dried to obtain the mPEG grafted thioacetal.
5. The method for preparing the modified hollow mesoporous silica nanogel according to claim 1, characterized in that: In step D, the reaction time is 12-36 hours; the rotation speed range of high-speed separation is 7000-9000 rpm; after separation, the solid is washed with ethanol and / or methanol, and washed with water.
6. The method for preparing the modified hollow mesoporous silica nanogel according to claim 1, characterized in that: In step E, the solvent is selected from at least one of dichloromethane, chloroform, and 1,2-dichloroethane; the reaction time is 24-72 hours; after separation, the solid is washed with acetone or ether, washed with water, and then dispersed in ultrapure water and vacuum dried.
7. Use of the modified hollow mesoporous silica nanogel obtained by the preparation method according to any one of claims 1 to 6 in preparing drugs for treating periodontitis.
Citation Information
Patent Citations
Methoxypolyethylene-glycol-modified mesoporous silicon dioxide nanoparticle as well as preparation method and application thereof
CN104193982A
Anti-periodontitis medicine and preparation method thereof
CN115813922A
Universal multi-functional GSH-responsive silica nanoparticles for delivery of biomolecules into cells
US20220105202A1
